Hiroyuki Masuko

Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial

Tetsuya Hamaguchi, Yasuhiro Shimada, Junki Mizusawa et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 59 citations

Medicine, Oncology, Pharmacology +13

The Primary Result of Prospective Randomized Multicenter Trial of New Spray-Type Bio-absorbable Adhesion Barrier System (TCD-11091) Against Postoperative Adhesion Formation

Takeshi Suto, Masahiko Watanabe, Takeshi Endo et al. · Journal of Gastrointestinal Surgery · 2017 · 47 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Open‐label, randomized, comparative, phase <scp>III</scp> study on effects of reducing steroid use in combination with Palonosetron

Yoshito Komatsu, Kenji Okita, Satoshi Yuki et al. · Cancer Science · 2015 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Laparoscopic gastrectomy for early gastric cancer targeting as a less invasive procedure

Hideki Kawamura, Kuniaki Okada, Hiroyuki Isizu et al. · Surgical Endoscopy · 2007 · 43 citations

Medicine, Oncology, Surgery +13

PROLONGATION OF CANINE LIVER ALLOGRAFT SURVIVAL BY A NOVEL IMMUNOSUPPRESSANT, FTY720

Hiroyuki Furukawa, Tomomi Suzuki, Maeng Bong Jin et al. · Transplantation · 2000 · 43 citations

Medicine, Pharmacotherapy, Surgery +17